Stay updated on Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNo significant changes to the study details, eligibility criteria, outcomes, or locations; only minor formatting and layout adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check37 days agoChange DetectedKey changes: published a government-funding status notice affecting operations and a new version v3.2.0; the previous v3.1.0 deletion indicates an update rather than a removal of functionality.SummaryDifference3%

- Check44 days agoChange DetectedUpdated software version from v3.0.2 to v3.1.0, marking an iteration in the product page.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated to v3.0.2 from v3.0.1, and the 'Back to Top' link was removed. Core content, pricing, stock availability, and time-slot information are unchanged.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has added significant information regarding a facility, its location, and a list of relevant publications, while removing various terms and resources related to stomach cancer and other neoplasms.SummaryDifference10%

Stay in the know with updates to Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.